- Report
- August 2024
- 119 Pages
Asia Pacific
From €1365EUR$1,500USD£1,170GBP
- Report
- May 2024
- 100 Pages
Africa
From €1820EUR$2,000USD£1,560GBP
- Report
- April 2024
- 80 Pages
United States
From €1365EUR$1,500USD£1,170GBP
- Report
- April 2024
- 80 Pages
United States
From €1365EUR$1,500USD£1,170GBP
- Report
- April 2024
- 100 Pages
Africa
From €1820EUR$2,000USD£1,560GBP
- Report
- February 2025
- 95 Pages
North America
From €5456EUR$5,995USD£4,677GBP
- Report
- February 2025
- 111 Pages
Europe
From €5456EUR$5,995USD£4,677GBP
- Report
- February 2025
- 107 Pages
Asia Pacific
From €5456EUR$5,995USD£4,677GBP
- Report
- December 2024
- 69 Pages
North America
From €5456EUR$5,995USD£4,677GBP
- Report
- December 2024
- 85 Pages
Europe
From €5456EUR$5,995USD£4,677GBP
- Report
- December 2024
- 89 Pages
Asia Pacific
From €5456EUR$5,995USD£4,677GBP
- Report
- December 2024
- 40 Pages
United States
From €4546EUR$4,995USD£3,897GBP
- Report
- September 2024
- 50 Pages
North America
From €5456EUR$5,995USD£4,677GBP
- Report
- September 2024
- 67 Pages
Europe
From €5456EUR$5,995USD£4,677GBP
- Report
- September 2024
- 69 Pages
Asia Pacific
From €5456EUR$5,995USD£4,677GBP
- Report
- May 2024
- 100 Pages
Africa
From €1820EUR$2,000USD£1,560GBP
- Report
- May 2024
- 100 Pages
Africa
From €1820EUR$2,000USD£1,560GBP
- Report
- May 2024
- 80 Pages
United States
From €1365EUR$1,500USD£1,170GBP
- Report
- April 2024
- 80 Pages
United States
From €1365EUR$1,500USD£1,170GBP
- Report
- April 2024
- 80 Pages
United States
From €1365EUR$1,500USD£1,170GBP

The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more